The Safety and Efficacy of Early-stage Bi-weekly Alendronate to Improve Bone Mineral Density and Bone Turnover in Chinese Post-menopausal Women at Risk of Osteoporosis

Author： You L   Sheng Z-Y   Chen J-Y   Pan L   Chen L  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.1, 2011-01, pp. : 302-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study

By Hejdova Miroslava   Palicka Vladimir   Kucera Zdenek   Vlcek Jiri  

Pharmacy World and Science, Vol. 27, Iss. 3, 2005-06 ,pp. : 149-153

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Combined Treatment with Calcitriol plus Alendronate on Bone Mass and Bone Turnover in Postmenopausal Osteoporosis: Two Years of Continuous Treatment

By Frediani B.   Allegri A.   Bisogno S.   Marcolongo R.  

Clinical Drug Investigation, Vol. 15, Iss. 3, 1998-03 ,pp. : 235-244

Adis International

Access to resources Recommend Favorite

Anastrozole use does not appear to change bone mineral density (BMD) or bone turnover markers in postmenopausal Japanese women with breast cancer

By  

Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

A Comparative Study on Biochemical Markers of Bone Collagen Breakdown in Post-Menopausal Women

By Sirtori P.   Sosio C.   Polo R.M.A.R.C.O.   Tenni R.   Rubinacci A.  

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 229-235

Academic Press

Access to resources Recommend Favorite

Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis: Results of FACTS1 1 Fosamax Actonel Comparison Trials. -International

By Reid David M.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 63-74

Adis International

Access to resources Recommend Favorite